CHF get a new seat on PBAC


Jo Watson (centre) with fellow review panelists Professor Steven King (l) and Bill Scott.

Consumers’ group deputy head now gains a senior role on key PBS committee

Federal Health Minister Greg Hunt has announced that Jo Watson, deputy chair of the Consumers Health Forum is the new second in command of the Pharmaceutical Benefits Advisory Committee (PBAC).

Ms Watson, recently a member of the panel of the controversial Review of Pharmacy Remuneration and Regulation (King Review) is the inaugural deputy chairperson of PBAC.

One of three appointments announced today, Ms Watson has “extensive experience as a PBAC member and is also the Chair of the Health Technology Assessment Consumer Consultative Committee, formed to improve consumer engagement in the area of Health Technology Assessment”, according to the Department of Health release.

The other two appointments are an endocrinologist and a haematologist.

Public health researcher and epidemiologist Professor Andrew Wilson is the current PBAC chair.

The pharmacy representative on the PBAC board is Associate Professor David Newby, acting Discipline Lead in Clinical Pharmacology, Joint Medical Program, and the Course coordinator for Epidemiology and pharmacoeconomics, Master of Pharmacy Program in the Faculty of Health at the University of Newcastle.

According to the Department of Health “these new appointments raise the Committee’s membership to its full capacity, enhancing its ability to address the growing number of increasingly complex submissions”.

“The PBAC is now fully constituted with 21 members, fulfilling the Australian Government’s commitment under the PBS Access and Sustainability Package of reforms announced in May 2015”.

Click here for more information on the PBAC committee

Previous Just dropping in
Next Incorrect disposal

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply